circRNAs in drug resistance of breast cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

circRNAs in drug resistance of breast cancer

Published:2022 Issue:4 Volume:30 Page:157-172
ISSN:0965-0407
Container-title:Oncology Research
language:en
Short-container-title:

Author:

MISIR SEMA,OZER YAMAN SERAP,PETROVIĆ NINA,SUMER CEREN,HEPOKUR CEYLAN,ALIYAZICIOGLU YUKSEL

Publisher

Computers, Materials and Continua (Tech Science Press)

Subject

Cancer Research,Oncology,General Medicine

Link

https://www.techscience.com/or/v30n4/51394/pdf

Reference141 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA: A Cancer Journal for Clinicians,2021

2. The effect of the new eighth edition breast cancer staging system on 100 consecutive patients;Biswal;Journal of Clinical Medicine Research,2019

3. Clinical implications of the intrinsic molecular subtypes of breast cancer;Prat;Breast,2015

4. Triple negative breast cancer: A mountain yet to be scaled despite the triumphs;Wu;Cancers,2021

5. The lingering mysteries of metastatic recurrence in breast cancer;Riggio;British Journal of Cancer,2021

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circular RNAs as a novel molecular mechanism in diagnosis, prognosis, therapeutic target, and inhibiting chemoresistance in breast cancer;Pathology - Research and Practice;2024-11

2. The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancer;Cancer Drug Resistance;2024-08-19

3. CircUGGT2 facilitates progression and cisplatin resistance of bladder cancer through nonhomologous end-joining pathway;Cellular Signalling;2024-07

4. The therapeutic potential of circular RNA in triple-negative breast cancer;Cancer Drug Resistance;2024-04-23

5. SOX13 is a novel prognostic biomarker and associates with immune infiltration in breast cancer;Frontiers in Immunology;2024-04-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3